创业板50指数首次登陆泰国

Group 1: Company Overview - Company generates approximately 85% of its revenue from overseas clients, serving around 3,000 global customers annually, including the top 20 pharmaceutical companies [1] - Company is recognized as a leading provider of integrated, international, and multi-therapy innovative drug research and development services, offering a one-stop solution from drug discovery to commercialization [1] Group 2: Industry Performance - In the first three quarters, the company's power battery shipments reached 34.59 GWh, representing a year-on-year increase of 66.98%, ranking second globally [1] - The company's energy storage battery shipments reached 48.41 GWh, with a year-on-year growth of 35.51%, placing it among the top three globally [1] - The company's overseas sales percentages for 2022, 2023, and 2024 are projected to be 34.79%, 27.27%, and 24.25%, respectively, indicating steady growth [1] Group 3: Future Outlook - The company plans to continue focusing on its lithium battery core business, increasing R&D investment, and enhancing global operational capabilities through technology upgrades and capacity optimization [1] - The company is expanding its global footprint by establishing new production bases, including a recent facility in Thailand, which is expected to create around 2,000 jobs and meet the demand for smart automotive products [1] - Future plans include further establishing production bases to provide AI-related hardware products to overseas clients [1]